Two new studies released in 2025 provide a mixed picture of how well our current antivirals are holding up against H5N1, the ...
Bird flu has long been a top contender for starting the next pandemic. Between 2003 and 2023, there were 882 cases reported ...
Preclinical and Phase 1 data suggest that ratutrelvir can be used without ritonavir and may reduce the likelihood of COVID rebound and the risk ...
Tivoxavir marboxil (TXM), administered as a single dose in non-human primates, significantly reduced lung viremia and prevented weight loss, two ...
Potent Antiviral Activity in Preclinical Challenge Model: Results from a rodent challenge model showed that 100% of mice ...